The Three Pillars of ATP Production in Mammalian Sperm: Integrating Gluconeogenesis Into the Metabolic Framework
Reproductive Medicine and Biology · 2026-01 · 25 (1)
DOI: 10.1002/rmb2.70017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 16.01.2026. Verfasst von Kosei Oishi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Engineering Science Yokohama National University Yokohama Kanagawa Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Purpose
Mammalian sperm require a large amount of ATP to sustain motility. While glycolysis and oxidative phosphorylation (OXPHOS) are established ATP sources, they cannot fully explain motility maintenance under glucose‐deprived conditions. This study examined whether gluconeogenesis functions as a third metabolic pathway supporting sperm energy production.
Methods
Sperm from mice, humans, cattle, and horses were comparatively analyzed under glucose‐containing and glucose‐free conditions with inhibitors of OXPHOS (FCCP) and fructose‐1,6‐bisphosphatase 1 (FBPase1). Motility and ATP levels were measured, and FBPase1 expression was assessed by Western blotting and immunofluorescence.
Results
Mouse sperm maintained motility without glucose, and inhibition of FBPase1 significantly reduced ATP and rapid progressive motility. FBPase1 was expressed in the midpiece and principal piece, indicating active gluconeogenesis. Similar patterns were observed in human and bovine sperm, suggesting a conserved mechanism among mammals.
Conclusion
Gluconeogenesis serves as a third metabolic platform that complements glycolysis and OXPHOS, enabling efficient substrate use and sustaining sperm motility. This discovery provides new insight into sperm metabolic flexibility and may contribute to treatments for male infertility and improved livestock reproduction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Engineering Science Yokohama National University Yokohama Kanagawa Japan.
- Department of Urology, Reproduction Center Yokohama City University Medical Center Yokohama Kanagawa Japan.
- Center for Natural Sciences Kitasato University, College of Liberal Arts and Sciences Sagamihara Kanagawa Japan.
- Faculty of Biomedical Engineering Toin University of Yokohama Yokohama Kanagawa Japan.
- Tokachi Station National Livestock Breeding Center Hokkaido Japan.
- Graduate School of Animal and Veterinary Sciences and Agriculture Obihiro University of Agriculture and Veterinary Medicine Obihiro Hokkaido Japan.
ORCID-Profile: Yasushi Yumura, Manabu Yoshida, Kaoru Yoshida, Hiroyuki Watanabe, Yuki Muranishi, Yasuyuki Kurihara
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Oishi, K., Tokito, R., Yumura, Y., Yoshida, M., Yoshida, K., Asada, M., Mikami, K., Watanabe, H., Muranishi, Y., & Kurihara, Y. (2026). The Three Pillars of ATP Production in Mammalian Sperm: Integrating Gluconeogenesis Into the Metabolic Framework. Reproductive Medicine and Biology, 25(1). https://doi.org/10.1002/rmb2.70017
Vancouver
Oishi K, Tokito R, Yumura Y, Yoshida M, Yoshida K, Asada M, et al. The Three Pillars of ATP Production in Mammalian Sperm: Integrating Gluconeogenesis Into the Metabolic Framework. Reproductive Medicine and Biology. 2026;25(1). doi:10.1002/rmb2.70017
BibTeX
@article{Oishi2026,
author = {Oishi, Kosei and Tokito, Reiji and Yumura, Yasushi and Yoshida, Manabu and Yoshida, Kaoru and Asada, Masatsugu and Mikami, Koyuki and Watanabe, Hiroyuki and Muranishi, Yuki and Kurihara, Yasuyuki},
title = {The Three Pillars of ATP Production in Mammalian Sperm: Integrating Gluconeogenesis Into the Metabolic Framework},
journal = {Reproductive Medicine and Biology},
year = {2026},
volume = {25},
number = {1},
doi = {10.1002/rmb2.70017}
}
EUVIMED